Expert Opinion on Drug Safety

The safety of obesity drugs - correspondence
pp. 475-476(2)
Authors: Van Gaal, Luc F; Scheen, André J; Formiguera, Xavier

The safety of obesity drugs - authors' response
pp. 477-478(2)
Authors: Greenway, Frank; Caruso, Mary Katherine

The use of tacrolimus in the treatment of inflammatory bowel disease
pp. 479-485(7)
Authors: Chow, Dorothy KL; Leong, Rupert WL

Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: a risk-based perspective
pp. 487-491(5)
Author: Markovic, Ingrid

The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy
pp. 493-503(11)
Authors: Almeida, John A; Riordan, Stephen M

Assessment of safety of the major antimalarial drugs
pp. 505-521(17)
Authors: Chattopadhyay, Rana; Mahajan, Babita; Kumar, Sanjai

Safety of aerosolized amphotericin B
pp. 523-532(10)
Authors: Knechtel, Stephanie A; Klepser, Michael E

Off-label use of antipsychotics: are we mad?
pp. 533-545(13)
Authors: Haw, Camilla; Stubbs, Jean

Increased propensity for calcium phosphate kidney stones with topiramate use
pp. 547-557(11)
Authors: Vega, Damaris; Maalouf, Naim M; Sakhaee, Khashayar

A review of the safety of 50% nitrous oxide/oxygen in conscious sedation
pp. 559-571(13)
Authors: Collado, Valérie; Nicolas, Emmanuel; Faulks, Denise; Hennequin, Martine

The safety of rosuvastatin: effects on renal and hepatic function
pp. 573-581(9)
Authors: Guthrie, Robert M; Martin, Daniel R

Strategies to improve the cardiovascular risk profile of thiazide-type diuretics as used in the management of hypertension
pp. 583-594(12)
Authors: Carter, Barry L; Sica, Domenic A

Quality assessment of digital annotated ECG data from clinical trials by the FDA ECG warehouse
pp. 595-607(13)
Author: Sarapa, Nenad

Paclitaxel: a review of adverse toxicities and novel delivery strategies
pp. 609-621(13)
Authors: Marupudi, Neena I; Han, James E; Li, Khan W; Renard, Violette M; Tyler, Betty M; Brem, Henry